Landscapes / Companies
Prime Medicine, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
Drugs
3
in active trials
Trials
3 active
3 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Nov 2028Phase 1/2 trial completes | |||
| Next date | Nov 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Wilson Disease, Wilson's Disease and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2028Phase 1/2 trial completes | |||
| Next date | Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Alpha-1 Antitrypsin Deficiency, Alpha-1 Antitrypsin Deficiency-associated Lung Disease and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jan 2030Phase 1/2 trial completes | |||
| Next date | Jan 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Chronic Granulomatous Disease, Granulomatous Disease, Chronic | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021